Progression from concentric left ventricular hypertrophy and normal ejection fraction to left ventricular dysfunction

Richard V. Milani, Mark H. Drazner, Carl J. Lavie, Daniel P. Morin, Hector O. Ventura

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Concentric left ventricular (LV) hypertrophy develops in response to a chronically increased LV afterload and is associated with increased cardiovascular events. Although the progression to systolic and diastolic heart failure is a known consequence of LV hypertrophy, few data are available on the frequency of deterioration to systolic dysfunction in patients with LV hypertrophy who originally had a normal LV ejection fraction. We evaluated the baseline and follow-up characteristics in 1,024 patients with concentric LV hypertrophy and a normal ejection fraction who had paired echocardiograms that were separated by <1 year. Systolic dysfunction occurred in 134 patients (13%) after a mean follow-up of 33 ± 24 months. The most common associated variable was interval myocardial infarction, which occurred in 43% of patients. Other risk factors for developing LV systolic dysfunction included QRS prolongation (>120 ms) and elevated follow-up arterial impedance defined as a value >4.0 mm Hg/ml/m2. Patients with either a prolonged QRS interval or an elevated follow-up arterial impedance had twice the likelihood of developing LV systolic dysfunction, and, if both factors were present, there was a greater than fourfold increased risk of developing systolic dysfunction. Blood pressure measurements alone did not adequately reflect an elevated arterial impedance. In conclusion, 13% of patients with a normal ejection fraction and concentric LV hypertrophy progress to systolic dysfunction during approximately 3 years of follow-up. The risk factors for loss of function were interval myocardial infarction, prolonged QRS, and chronically elevated arterial impedance.

Original languageEnglish (US)
Pages (from-to)992-996
Number of pages5
JournalAmerican Journal of Cardiology
Volume108
Issue number7
DOIs
StatePublished - Oct 1 2011

Fingerprint

Left Ventricular Dysfunction
Left Ventricular Hypertrophy
Electric Impedance
Diastolic Heart Failure
Systolic Heart Failure
Stroke Volume
Myocardial Infarction
Blood Pressure

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Progression from concentric left ventricular hypertrophy and normal ejection fraction to left ventricular dysfunction. / Milani, Richard V.; Drazner, Mark H.; Lavie, Carl J.; Morin, Daniel P.; Ventura, Hector O.

In: American Journal of Cardiology, Vol. 108, No. 7, 01.10.2011, p. 992-996.

Research output: Contribution to journalArticle

Milani, Richard V. ; Drazner, Mark H. ; Lavie, Carl J. ; Morin, Daniel P. ; Ventura, Hector O. / Progression from concentric left ventricular hypertrophy and normal ejection fraction to left ventricular dysfunction. In: American Journal of Cardiology. 2011 ; Vol. 108, No. 7. pp. 992-996.
@article{6f6f8f122d4840848ae101975592f2a9,
title = "Progression from concentric left ventricular hypertrophy and normal ejection fraction to left ventricular dysfunction",
abstract = "Concentric left ventricular (LV) hypertrophy develops in response to a chronically increased LV afterload and is associated with increased cardiovascular events. Although the progression to systolic and diastolic heart failure is a known consequence of LV hypertrophy, few data are available on the frequency of deterioration to systolic dysfunction in patients with LV hypertrophy who originally had a normal LV ejection fraction. We evaluated the baseline and follow-up characteristics in 1,024 patients with concentric LV hypertrophy and a normal ejection fraction who had paired echocardiograms that were separated by <1 year. Systolic dysfunction occurred in 134 patients (13{\%}) after a mean follow-up of 33 ± 24 months. The most common associated variable was interval myocardial infarction, which occurred in 43{\%} of patients. Other risk factors for developing LV systolic dysfunction included QRS prolongation (>120 ms) and elevated follow-up arterial impedance defined as a value >4.0 mm Hg/ml/m2. Patients with either a prolonged QRS interval or an elevated follow-up arterial impedance had twice the likelihood of developing LV systolic dysfunction, and, if both factors were present, there was a greater than fourfold increased risk of developing systolic dysfunction. Blood pressure measurements alone did not adequately reflect an elevated arterial impedance. In conclusion, 13{\%} of patients with a normal ejection fraction and concentric LV hypertrophy progress to systolic dysfunction during approximately 3 years of follow-up. The risk factors for loss of function were interval myocardial infarction, prolonged QRS, and chronically elevated arterial impedance.",
author = "Milani, {Richard V.} and Drazner, {Mark H.} and Lavie, {Carl J.} and Morin, {Daniel P.} and Ventura, {Hector O.}",
year = "2011",
month = "10",
day = "1",
doi = "10.1016/j.amjcard.2011.05.038",
language = "English (US)",
volume = "108",
pages = "992--996",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Progression from concentric left ventricular hypertrophy and normal ejection fraction to left ventricular dysfunction

AU - Milani, Richard V.

AU - Drazner, Mark H.

AU - Lavie, Carl J.

AU - Morin, Daniel P.

AU - Ventura, Hector O.

PY - 2011/10/1

Y1 - 2011/10/1

N2 - Concentric left ventricular (LV) hypertrophy develops in response to a chronically increased LV afterload and is associated with increased cardiovascular events. Although the progression to systolic and diastolic heart failure is a known consequence of LV hypertrophy, few data are available on the frequency of deterioration to systolic dysfunction in patients with LV hypertrophy who originally had a normal LV ejection fraction. We evaluated the baseline and follow-up characteristics in 1,024 patients with concentric LV hypertrophy and a normal ejection fraction who had paired echocardiograms that were separated by <1 year. Systolic dysfunction occurred in 134 patients (13%) after a mean follow-up of 33 ± 24 months. The most common associated variable was interval myocardial infarction, which occurred in 43% of patients. Other risk factors for developing LV systolic dysfunction included QRS prolongation (>120 ms) and elevated follow-up arterial impedance defined as a value >4.0 mm Hg/ml/m2. Patients with either a prolonged QRS interval or an elevated follow-up arterial impedance had twice the likelihood of developing LV systolic dysfunction, and, if both factors were present, there was a greater than fourfold increased risk of developing systolic dysfunction. Blood pressure measurements alone did not adequately reflect an elevated arterial impedance. In conclusion, 13% of patients with a normal ejection fraction and concentric LV hypertrophy progress to systolic dysfunction during approximately 3 years of follow-up. The risk factors for loss of function were interval myocardial infarction, prolonged QRS, and chronically elevated arterial impedance.

AB - Concentric left ventricular (LV) hypertrophy develops in response to a chronically increased LV afterload and is associated with increased cardiovascular events. Although the progression to systolic and diastolic heart failure is a known consequence of LV hypertrophy, few data are available on the frequency of deterioration to systolic dysfunction in patients with LV hypertrophy who originally had a normal LV ejection fraction. We evaluated the baseline and follow-up characteristics in 1,024 patients with concentric LV hypertrophy and a normal ejection fraction who had paired echocardiograms that were separated by <1 year. Systolic dysfunction occurred in 134 patients (13%) after a mean follow-up of 33 ± 24 months. The most common associated variable was interval myocardial infarction, which occurred in 43% of patients. Other risk factors for developing LV systolic dysfunction included QRS prolongation (>120 ms) and elevated follow-up arterial impedance defined as a value >4.0 mm Hg/ml/m2. Patients with either a prolonged QRS interval or an elevated follow-up arterial impedance had twice the likelihood of developing LV systolic dysfunction, and, if both factors were present, there was a greater than fourfold increased risk of developing systolic dysfunction. Blood pressure measurements alone did not adequately reflect an elevated arterial impedance. In conclusion, 13% of patients with a normal ejection fraction and concentric LV hypertrophy progress to systolic dysfunction during approximately 3 years of follow-up. The risk factors for loss of function were interval myocardial infarction, prolonged QRS, and chronically elevated arterial impedance.

UR - http://www.scopus.com/inward/record.url?scp=80052697881&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052697881&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2011.05.038

DO - 10.1016/j.amjcard.2011.05.038

M3 - Article

C2 - 21784383

AN - SCOPUS:80052697881

VL - 108

SP - 992

EP - 996

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 7

ER -